Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
T. Ruskovska, S. J Bennett, C. R. Brown, S. Dimitrov, N. Kamcev & H. R. Griffiths. (2015) Ankyrin is the major oxidised protein in erythrocyte membranes from end-stage renal disease patients on chronic haemodialysis and oxidation is decreased by dialysis and vitamin C supplementation. Free Radical Research 49:2, pages 175-185.
Read now
Read now
Marian Goicoechea, Borja Quiroga, Soledad García de Vinuesa, Úrsula Verdalles, Javier Reque, Nayara Panizo, David Arroyo, Alba Santos, Nicolás Macías & José Luño. (2012) Intraindividual Interleukin-6 Variations on the Cardiovascular Prognosis of Patients with Chronic Renal Disease. Renal Failure 34:8, pages 1002-1009.
Read now
Read now
Rüya Mutluay, Ceyla Konca, Yasemin Erten, Hatice Paşaoğlu, Serpil Müge Değer, Çağri Ağirgün, Ülver Derici, Turgay Arinsoy & Şükrü Sindel. (2010) Predictive markers of asymptomatic atherosclerosis in end-stage renal disease patients. Renal Failure 32:4, pages 448-454.
Read now
Read now
Csaba P Kovesdy & Kamyar Kalantar-Zadeh. (2008) Novel targets and new potential: developments in the treatment of inflammation in chronic kidney disease. Expert Opinion on Investigational Drugs 17:4, pages 451-467.
Read now
Read now
Articles from other publishers (22)
Carina Ureche, Gianina Dodi, Adela Mihaela Șerban, Andreea Simona Covic, Luminița Voroneanu, Simona Hogaș, Radu Andy Sascău, Cristian Stătescu & Adrian Covic. (2023) Predictive Value of Collagen Biomarkers in Advanced Chronic Kidney Disease Patients. Biomolecules 13:2, pages 389.
Crossref
Crossref
Jose Augusto Nogueira-Machado, Gabriela Rossi Ferreira, Caroline Maria Oliveira Volpe, Pedro Henrique Villar-Delfino & Fabiana Rocha Silva. (2021) Diabetes potentiates ROS production in granulocytes from patients with chronic kidney disease. Endocrinology&Metabolism International Journal 9:1, pages 9-14.
Crossref
Crossref
Tao Zhang, Shili Cao, Hongtao Yang & Jing Li. (2019) Prognostic impact of galectin-3 in chronic kidney disease patients: a systematic review and meta-analysis. International Urology and Nephrology 51:6, pages 1005-1011.
Crossref
Crossref
Ali Abdulmajid Dyab Allawi. (2018) Malnutrition, inflamation and atherosclerosis (MIA syndrome) in patients with end stage renal disease on maintenance hemodialysis (a single centre experience). Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12:2, pages 91-97.
Crossref
Crossref
Simona Hogas, Adalbert Schiller, Luminita Voroneanu, Daniela Constantinescu, Romulus Timar, Petru Cianga, Dimitrie Siriopol, Flaviu Bob, Corina Cianga, Mihai Onofriescu, Florica Gadalean, Mihai Hogas, Adelina Mihaescu, Stefana Catalina Bilha, Bogdan Timar, Mehmet Kanbay, Maciej Banach & Adrian Covic. (2016) Predictive Value for Galectin 3 and Cardiotrophin 1 in Hemodialysis Patients. Angiology 67:9, pages 854-859.
Crossref
Crossref
B. Sjoberg, S. Snaedal, P. Stenvinkel, A. R. Qureshi, O. Heimburger & P. Barany. (2014) Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients. Clinical Kidney Journal 7:4, pages 373-379.
Crossref
Crossref
Yoshiyuki Morishita, Eiji Kusano & Daisuke Nagata. (2014) Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis. The Open Cardiovascular Medicine Journal 8:1, pages 6-11.
Crossref
Crossref
Sabina Skrgat Kristan. (2013) Blood Specimen Biomarkers of Inflammation, Matrix Degradation, Angiogenesis, and Cardiac Involvement: a Future Useful Tool in Assessing Clinical Outcomes of COPD Patients in Clinical Practice?. Archivum Immunologiae et Therapiae Experimentalis 61:6, pages 469-481.
Crossref
Crossref
Csaba Kovesdy & Kamyar Kalantar-Zadeh. 2013. Nutritional Management of Renal Disease. Nutritional Management of Renal Disease
171
195
.
Yoshiyuki Morishita & Eiji Kusano. (2012) Direct Renin Inhibitor: Aliskiren in Chronic Kidney Disease. Nephro-Urology Monthly 5:1, pages 668-672.
Crossref
Crossref
C. L. Meuwese, S. Snaedal, N. Halbesma, P. Stenvinkel, F. W. Dekker, A. R. Qureshi, P. Barany, O. Heimburger, B. Lindholm, R. T. Krediet, E. W. Boeschoten & J. J. Carrero. (2010) Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor- are similarly associated with survival in haemodialysis patients. Nephrology Dialysis Transplantation 26:4, pages 1313-1318.
Crossref
Crossref
Yoshiyuki Morishita, Shiho Hanawa, Junko Chinda, Osamu Iimura, Sadao Tsunematsu & Eiji Kusano. (2010) Effects of Aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension. Hypertension Research 34:3, pages 308-313.
Crossref
Crossref
Csaba P. Kovesdy & Kamyar Kalantar-Zadeh. 2010. Chronic Kidney Disease, Dialysis, and Transplantation. Chronic Kidney Disease, Dialysis, and Transplantation
183
197
.
Friso L.H. Muntinghe, Marion Verduijn, Mike W. Zuurman, Diana C. Grootendorst, Juan Jesus Carrero, Abdul Rashid Qureshi, Karin Luttropp, Louise Nordfors, Bengt Lindholm, Vincent Brandenburg, Martin Schalling, Peter Stenvinkel, Elisabeth W. Boeschoten, Raymond T. Krediet, Gerjan Navis & Friedo W. Dekker. (2009) CCR5 Deletion Protects Against Inflammation-Associated Mortality in Dialysis Patients. Journal of the American Society of Nephrology 20:7, pages 1641-1649.
Crossref
Crossref
CSABA P KOVESDY & KAMYAR KALANTAR-ZADEH. (2009) Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease. Nephrology 14:4, pages 408-415.
Crossref
Crossref
Lakhmir S. CHAWLA & Mahesh KRISHNAN. (2009) Causes and consequences of inflammation on anemia management in hemodialysis patients. Hemodialysis International 13:2, pages 222-234.
Crossref
Crossref
B. D. Bradbury, C. W. Critchlow, M. R. Weir, R. Stewart, M. Krishnan & R. H. Hakim. (2008) Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients. Nephrology Dialysis Transplantation 24:3, pages 919-925.
Crossref
Crossref
JAMES B WETMORE, DAVID H LOVETT, ADRIANA M HUNG, GALEN COOK-WIENS, JONATHAN D MAHNKEN, SAUNAK SEN & KIRSTEN L JOHANSEN. (2008) Associations of interleukin-6, C-reactive protein and serum amyloid A with mortality in haemodialysis patients. Nephrology 13:7, pages 593-600.
Crossref
Crossref
H. Stopper, A.-T. Treutlein, U. Bahner, N. Schupp, U. Schmid, A. Brink, A. Perna & A. Heidland. (2008) Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation. Nephrology Dialysis Transplantation 23:10, pages 3272-3279.
Crossref
Crossref
Juan P. de Torres, Victor Pinto-Plata, Ciro Casanova, Hanna Mullerova, Elizabeth Córdoba-Lanús, Mercedes Muros de Fuentes, Armando Aguirre-Jaime & Bartolome R. Celli. (2008) C-Reactive Protein Levels and Survival in Patients With Moderate to Very Severe COPD. Chest 133:6, pages 1336-1343.
Crossref
Crossref
Hanaâ Lahrach, Noreddine Ghalim, Hassan Taki, Anass Kettani, Loubna Er-Rachdi, Benyounes Ramdani & Rachid Saïle. (2008) Serum paraoxonase activity, high-sensitivity C-reactive protein, and lipoprotein disturbances in end-stage renal disease patients on long-term hemodialysis. Journal of Clinical Lipidology 2:1, pages 43-50.
Crossref
Crossref
Gavin C. Donaldson. (2007) C-reactive Protein. American Journal of Respiratory and Critical Care Medicine 175:3, pages 209-210.
Crossref
Crossref